Intellectual Property Newsletter by MeritsIP, August 27, 2025
Editor’s Note: Intellectual Property Highlights and Strategies for Innovation
Welcome to the MeritsIP Newsletter. We delve into critical updates in the intellectual property landscape, providing insights and strategies to help you navigate the ever-evolving world of patents, trademarks, and copyrights. Read on to stay informed and ahead in the game of innovation.
Zhuhai CosMX and CATL Take Their Notebook Battery Dispute to the Next Level
The dispute between Chinese battery manufacturers Zhuhai CosMX and Amperex Technology Limited (ATL) over lithium – ion batteries is intensifying in German courts. The German Federal Patent Court upheld the validity of an ATL patent (EP3627606B1) with restrictions, which may affect the second – instance infringement hearing.
This is part of a global legal battle in the US and China. In March 2024, the Munich Local Court ruled that Zhuhai CosMX and Acer infringed ATL’s patents. The Federal Patent Court, led by Judge Walter Schramm, maintained the patent’s validity but limited its protection scope. The patent protects an electrolyte formula for better battery performance.
Zhuhai CosMX filed two invalidation lawsuits in 2023 and 2024. The second one, by its subsidiary, was partially successful. The court merged the cases and limited the patent scope after considering Zhuhai CosMX’s test reports.
The first – instance infringement judgment is under appeal, with a hearing set for March 19, 2026. Zhuhai CosMX is also appealing a penalty order. Litigation is ongoing in China and the US, and a patent was recently revoked in a US court.
12 Reform Measures! Jiangsu Releases Implementation List of Intellectual Property “Micro – Reforms”
Recently, the Jiangsu Provincial Intellectual Property Office released the 2025 full – chain intellectual property protection “micro – reform” implementation list with 12 measures covering prefecture – level and county – level IP offices. It focuses on four key IP protection directions: strengthening foreign – related protection, improving patent administrative adjudication efficiency, deepening administrative – judicial protection coordination, and optimizing public services. Specific measures include cross – border e – commerce IP protection, overseas rights protection networks, law – enforcement force sinking, expediting simple case adjudication, and more. This list is an important part of Jiangsu’s “Ten Improvement and Efficiency – Enhancement Actions”. The office will strengthen work linkage, establish a cross – departmental mechanism, conduct research, and promote typical experiences to ensure reform effectiveness and improve full – chain IP protection in Jiangsu.
Striving for Progress: Shaanxi Acceler
The provided text seems incomplete. However, based on the given part, it appears to be about Shaanxi making efforts to strive for progress. Maybe it will further describe how Shaanxi acceler
2025.9.1 Effective: RMB Standard for EPO International Search Fees under China-EU PCT Pilot Project
The China National Intellectual Property Administration (CNIPA) has announced that starting from September 1, 2025, it will collect the international search fees of the European Patent Office (EPO) under the China-EU PCT International Searching Authority Pilot Project. The CNIPA will collect 15,490 yuan on behalf of the EPO, based on the RMB standard of PCT application fees at the international stage announced by the World Intellectual Property Organization. Any changes to the RMB standard will be notified separately. This standard applies to PCT applications submitted to the CNIPA with a receipt date on or after September 1, 2025, and which select the EPO as the international searching authority.
Libya’s New Trademark Renewal Regulations: Strategies for Chinese Enterprises
This article analyzes Libya’s new trademark renewal regulations, the potential risks they pose to Chinese enterprises, and presents effective trademark – protection strategies. Libya has raised trademark renewal fees, especially for foreign rights – holders, and added new requirements. In June 2025, the Libyan Trademark Office introduced “statutory cancellation procedures” and a “three – year exclusive registration period” to tackle trademark squatting after non – renewal. The new regulations aim to boost fiscal revenue and plug institutional loopholes, but they bring risks such as administrative delays, decision – making difficulties, and review challenges during re – registration. Chinese enterprises can cope with these risks by: accurately assessing and planning ahead; using the “three – year exclusive registration period” to submit re – registration applications; building a trademark use evidence system; and seeking local professional support and continuous monitoring.
Gilead Challenges Chinese Research Institution’s Remdesivir Patent at the Unified Patent Court
US biotech company Gilead has filed a revocation lawsuit at the Unified Patent Court (UPC) against a patent held by the Chinese Academy of Military Medical Sciences, which may affect the sales of the COVID – 19 drug remdesivir. The European Patent Office (EPO) granted a patent to the Beijing Academy of Military Medical Sciences, protecting the use of substituted aminopropionate compounds in treating coronavirus 2 infections, threatening remdesivir sales. Gilead developed the drug Veklury, initially for Ebola and Marburg virus infections and later for COVID – 19.
Gilead launched a two – pronged attack. After the patent got unified patent status in early June, Gilead filed an opposition with the EPO and a supplementary lawsuit with the Milan Central Division of the UPC. If the Central Division follows strict time limits, Gilead may get a ruling on the patent’s validity as early as next summer. The EPO will expedite the opposition procedure. The UPC case involves a Dutch judge, and the court will hear the case in English. Revocation lawsuits in the pharmaceutical industry have drawn much attention since the UPC’s establishment.
UPC Court Rejects Dyson’s Core Injunction Request, Recognizing Dreame’s Independent Innovation in Hair Styling Products
In 2025, Dreame got certifications like being the “world’s first to create 180° foldable high – speed hair dryers”. The European Unified Patent Court (UPC) recently rejected Dyson’s application for provisional measures against Dreame’s core hair styling products. The Hamburg local division’s August 14, 2025 ruling stated that Dreame’s Airstyle pro and Pocket Neo products don’t infringe the involved patents, safeguarding Dreame’s European market operations and validating its independent technology.
Despite a tough injunction threat in a patentee – friendly European area and a newly – authorized patent in April 2025, Dreame demonstrated great litigation skills with a well – structured defense. Its forward – looking risk prevention and strong IP management system contributed to the victory.
The ruling set precedents, showing UPC’s jurisdiction and flexibility. Dreame’s self – developed hair care products are gaining global influence. With over 7000 patent applications (over 25% overseas), Dreame has become an international brand. This ruling acknowledges Dreame’s innovation and IP management and showcases Chinese enterprises’ improved ability to handle international IP issues.
Overseas News | Donald Trump Jr. Invests in a Patent Monetization Company for the Second Time This Year
In 2025, Donald Trump Jr., son of former US President Donald Trump, holds shares in SIM IP. Now, he owns a 5% stake in Fintiv, a patent monetization firm previously targeting mobile payments. It’s well – known in US patent litigation due to the “NHK – Fintiv Rule”. Fintiv received investments from Eric Schmidt and others and is seeking $300 million from Middle Eastern investors.
Donald Trump Jr. also bought land in Maine with Fintiv – related individuals. While some link his investment to Trump’s pardon of Fintiv founder’s son for illegal contributions, there’s no evidence of impropriety. The investment indicates the patent licensing business’s appeal to high – net – worth individuals.
Overseas News | Korea Electronics and Telecommunications Research Institute Sues Hisense over HEVC Standard Essential Patents
In 2025, multiple members of the US patent pool management organization Access Advance sued Transsion Holdings over HEVC standard essential patents on July 17, with initial plaintiffs including NEC, JVC, and Sun Patent Trust. Huawei joined via the Unified Patent Court (UPC) on August 4. The Korea Electronics and Telecommunications Research Institute (ETRI), a patent – pool member, is the latest plaintiff. It claims the patent rights of EP3258692 in the UPC and filed a lawsuit against Hisense Group and its Dutch agency at the Düsseldorf Local Court of the UPC on August 7, 2025, over the same patent. Hisense can either settle bilaterally with ETRI or get a license from the Access Advance patent pool. As of June 13, Hisense was handling a Nokia lawsuit unrelated to the HEVC Advance patent pool, and earlier this year, it reached a patent license agreement with DivX due to Brazilian litigation pressure.
Patent Non-Substantive Examination: Malta Joins the Club! [Guide to Maltese Invention Patent Application]
This news reports that Malta has become a new country offering invention patents without substantive examination. It’s a good option for those in urgent need of a patent certificate. There are three application routes: direct application to MIPO, through the Paris Convention within 12 months from the priority date, and via the PCT – EP route after getting a European patent (the PCT national – phase entry channel in Malta is temporarily closed). The official application languages are Maltese or English. Required materials vary by route. The application period is short, with authorization and certificate issuance within 1 – 2 months after acceleration, and the protection term is 20 years from the application date. Other countries with non – substantive patent examination include Luxembourg, Belgium, the Netherlands, and Nigeria.
About Us
MeritsIP: Your Global Intellectual Property Partner
At MeritsIP, we provide comprehensive IP services in biomedicine, medical devices, manufacturing, semiconductors, and AI. We support 200+ top clients globally with strategic, high-quality IP services.
Stay Connected
-
- Website: https://www.meritsipglobal.com
-
- LinkedIn: Follow us on LinkedIn
-
- Email: info@meritsip.com
© 2025 MeritsIP. All Rights Reserved.